S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

FDMT 4D Molecular Therapeutics Inc

4.58

-0.10 (-2.14%)

18 Jan 2025 - Closed

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

4D Molecular Therapeutics (NASDAQ:FDMT)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more 4D Molecular Therapeutics Charts.

4D Molecular Therapeutics (NASDAQ:FDMT)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more 4D Molecular Therapeutics Charts.

4D Molecular Therapeutics Inc News

Form 8-K - Current report
Saturday 11 January 2025 (1 week ago) • Edgar (US Regulatory)

4DMT Announces Positive Interim Data from 4D-150 SPECTRA Clinical Trial in DME and Alignment with FDA on Registrational Path
Saturday 11 January 2025 (1 week ago) • GlobeNewswire Inc.

4DMT Announces Landmark Publication of 4D-150 Preclinical Data for the Treatment of Neovascular Retinopathies in IOVS
Tuesday 17 December 2024 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 12 December 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Saturday 7 December 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

4DMT to Participate in Upcoming Investor Conferences and Ophthalmology Innovation Summit XIV
Friday 15 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

4DMT Reports Third Quarter 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones
Thursday 14 November 2024 (2 months ago) • GlobeNewswire Inc.

4DMT Announces Presentation at the 2024 North American Cystic Fibrosis Conference
Monday 23 September 2024 (4 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 19 September 2024 (4 months ago) • Edgar (US Regulatory)

More 4D Molecular Therapeutics Inc News Articles

Gold vs US Dollar

National Australia Bank

S&P ASX 300 Metals and M...

AUD vs US Dollar

Sterling vs AUD

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions